A Hub for Inventors
Primed for commercializing technology and bridging big ideas to the market
By The Numbers
UH maintains a strong intellectual property portfolio that continues to gain momentum every year. For several years now, UH has led the nation in royalty earnings among public universities without medical schools.
$65M Licensing Income FY19
Invention Disclosures FY19
U.S. Patents Issued FY19
|2021-023||Scalable inter-diffused zwitterionic polyurethanes for durable antibacterial coatings||A novel antibacterial zwitterionic polyurethane developed to form inter-diffused coating films with commercialized acrylic polyurethanes. The antibacterial property is due to the hydrophilic zwitterionic polyurethane. Long-term use for both Gram-negative and Gram-positive bacteria is highly…|
|2021-019||System and Methods for Estimating Sympathetic Arousal and Energy Production from Skin Conductance and Blood Cortisol Measurements||Skin conductance-based sympathetic sensors that can be embeded in wear technology that can measure the arousal cotisol levels in the blood for a more acturate reading. The sensor is able to estimate internal brain-related/neural states from the data that is collected from unobserved internal states…|
|2021-008||Novel Technology to Monitor Membrane Protein Trafficking for Drug Discovery and Drug Development||High-throughput screening (HTS) has enabled successful unbiased drug-discovery and development of novel therapies. Much of its success has to do with the membrane proteins targeted, and the drugs directed to receptors that have underlying roles in a myriad of diseases,including cancer, heart…|
|2021-003||Blue-emitting phosphors||Lighting accounts for 15%of global energy consumption. Replacing traditional lighting with an energy-efficient, phosphor-converted light-emitting diode(pc-LED) is one of the most convenient and affordable methods to drastically decrease energy consumption. Currently, commercially viable phosphors…|
|2021-002||Vaccines for the Prevention & Treatment of Breast Cancer||Unique amino acid sequences at the junctions of fusion or truncated proteins translated from chimeric RNAs form neoantigen peptide sites capable of inducing anti-tumor immune responses. Our objective is to find recurrent fusion transcripts that have the potential to generate candidate neoantigens…|
|2020-059||Engineering a novel single-chain viral membrane-protein complex of coronavirus (such as COVID-19 (SARS-Cov-2)) for more immunogenic vaccination and others||The current spike (S) protein-based vaccine for coronavirus (such as SARS-Cov-2) may have limited immunogenicity, duration of antibody production and ability resistant to the S-protein mutation. This invention is to engineer a novel single cDNA encoded a single polypeptide-chain of viral membrane…|
Check Out Plant-Based Polymers
New plant-based material discovered at UH could replace today's petroleum-based plastics.
University of Houston has developed breakthroughs in several therapeutic indications that have transformed patient lives around the world. UH is continuing to establish several key partnerships with the biopharma industry to push lab discoveries to the market. The status of these therapeutics is in pipeline can be explored below.